Le Lézard
Classified in: Health, Business
Subject: CXP

Science-Driven Lawyers Launch Shook New York Presence


NEW YORK, Jan. 19, 2021 /PRNewswire/ -- Expanding its strong bench of litigators based in the Northeast, Shook, Hardy & Bacon announces the addition of a New York office to complement its presence in Boston, Philadelphia and Washington, D.C. The firm welcomes two new partners who focus primarily on high-stakes product liability litigation in the pharmaceutical and medical device industries, among other areas. 

"We've had our eye on New York for some time because so many of our clients are based there," stated Shook Chair Madeleine McDonough, who divides her time between Washington, D.C. and Kansas City. "With offices in Boston, Philadelphia and D.C., the decision to expand into Manhattan is a natural progression. We searched for the right attorneys to better serve clients and align with our firm culture, and we have found them with this pair."

Partners Thomas Sheehan and Kimberly Penner have represented some of the world's largest pharmaceutical companies. Each has a long history working with Shook. Sheehan led his prior firm's Science Team Practice and brings more than 20 years of high-stakes product liability litigation in biologic products. He also brings an M.S. in epidemiology to his practice of the law. Penner has represented some of the world's most recognized pharmaceutical brands, with a focus on life sciences and health effects. She brings an M.S. in biochemistry and has extensive experience managing litigations spanning multiple jurisdictions.

"The lure for us is Shook's integration of law and science and their dominance in the pharmaceutical sphere," stated Sheehan. "It's the perfect marriage between how we serve pharmaceutical clients and where we want to practice."

Penner was drawn to Shook's scientific prowess which includes an in-house team of scientists and other individuals with advanced degrees to help prepare the expert-related aspects of their complex cases. The firm is known for having one of the largest team of product liability trial lawyers in the country. Penner says she has worked with Shook attorneys in product liability litigation across the country for more than 30 years.

"Shook is the whole package. They bring a strong science focus with unmatched analysts and support staff, combined with preeminence in pharmaceutical product liability litigation," stated Penner. "It's a very good fit for us, and we are excited to help shepherd the launch of the New York office."

The Northeast expansion follows the opening of new Shook offices in 2019 in Atlanta and Los Angeles, allowing the firm to serve its health, science and technology clients from 16 distinct markets. Shook's Product Liability Litigation Practice is co-led by Alicia Donahue and Hildy Sastre. The firm has represented more than 30 pharmaceutical and medical companies as national or regional counsel in matters involving more than 60 products.

"This is an exciting way to kick off the new year," stated McDonough. "Tom and Kimberly will quickly integrate and hit the ground running to help our clients."

About Shook, Hardy & Bacon

Founded in 1889, Shook, Hardy & Bacon L.L.P. has 16 offices in the United States and London, with attorneys and professional staff serving clients in the health, science and technology sectors in areas ranging from product liability defense and business litigation to intellectual property prosecution and litigation, environmental and toxic tort, privacy and data security and regulatory counseling.

SOURCE Shook, Hardy & Bacon L.L.P.


These press releases may also interest you

at 16:40
Pfizer Inc. today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company's common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The...

at 16:35
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting. Details for the public webcast are as follows: TIME:...

at 16:35
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....

at 16:35
Hapbee Technologies, Inc. ("Hapbee" or the "Company"), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company ("Units") for aggregate gross proceeds to the...

at 16:30
Collaboration on TSMC's COUPE silicon photonics platform dramatically speeds chip-to-chip and machine-to-machine communication for cloud, datacenters, HPC, and AI chips / Key Highlights Ansys and TSMC deliver a high-fidelity multiphysics solution to...

at 16:30
The Board of Directors of The Cigna Group today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024....



News published on and distributed by: